Fat-derived stem cells safe and feasible for SPMS, clinical trial

I have secondary progressive multiple sclerosis (SPMS) and am delighted with any advance in treating that form of the disease. This week, I am pleased that a clinical trial shows that fat-derived stem cells are a safe and feasible treatment for people with SPMS. The study, Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of … Continue reading Fat-derived stem cells safe and feasible for SPMS, clinical trial